Synvista Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$431K

175 transactions

Summary

Synvista Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $240KSales: —14 insiders

Date	Insider	Type	Value
2007-12-05	D'Amico Alex(principal accounting officer)	A	$27K
2007-11-21	Berkowitz Noah(President & CEO)	D	$7K
2007-11-01	Berkowitz Noah(President & CEO)	D	$5K
2007-11-01	Berkowitz Noah(President & CEO)	D	$3K
2007-10-19	Berkowitz Noah(President & CEO)	D	$3K
2007-11-01	Berkowitz Noah(President & CEO)	D	$550
2007-11-01	Berkowitz Noah(President & CEO)	D	$542
2007-11-01	Berkowitz Noah(President & CEO)	D	$502
2007-11-01	Berkowitz Noah(President & CEO)	D	$482
2008-12-01	Mendel Carl M(VP & Chief Medical Officer)	A	$0
2008-12-01	D'Amico Alex(principal accounting officer)	A	$0
2008-12-01	Berkowitz Noah(President & CEO)	A	$0
2008-12-01	Berkowitz Noah(President & CEO)	A	$0
2008-12-01	Milici Wendy Ann(Director of Finance)	A	$0
2008-10-06	FEDERICI WILLIAM J	A	$0
2008-07-22	Bedard John F.	A	$0
2008-07-22	TANNER MARY C	A	$0
2008-07-22	Yetter Wayne P.	A	$0
2008-07-22	Berkowitz Noah(President & CEO)	A	$0
2008-07-22	Berkowitz Noah(President & CEO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Synvista Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope